Research Reports

‘The Specialty Pharma Market Outlook’ evaluates the current specialty pharma models, financial performance, core strategies and future outlook of companies in the field. This report also examines key specialty markets, providing valuable insights into market dynamics while profiling trends that influence market opportunities in therapeutic indications.

Pharmaceutical and biopharmaceutical companies are currently confronted by a variety of complex issues affecting their operational efficiency and profitability. However, firms in the industry have recognized the opportunities and advantages that can be accessed by conducting clinical trials in the emerging markets.

The recruitment of patients for clinical trials is an essential part of the complex and inherently risky R&D process for pharmaceuticals. Operationally, patient recruitment involves targeting the right patients with the right messages and retaining enrolled patients with effective customer service.

No therapeutic cancer vaccine has received approval in any of the seven major pharmaceutical markets, despite extensive research efforts. However, with one product in pre-registration in the US, the prospect of the first marketed therapeutic cancer vaccine in the seven major markets is now closer to reality.

This growing commercial opportunity has encouraged companies to develop new technologies and increase manufacturing capacity for influenza vaccines and antivirals.